How many employees work at Zenara Pharma?
Zenara Pharma Pvt Ltd. has approximately 358 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Zenara Pharma’s total headcount has grown 16.7% from 307 employees in 2023 to 358 in 2026.
Is Zenara Pharma hiring right now?
No, Zenara Pharma is not actively hiring. Zenara Pharma had 0 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About Zenara Pharma’s Workforce
Zenara Pharma Pvt Ltd. is a Pharmaceuticals company that employs 358 people worldwide as of March 2026. It is the 11th-largest by headcount among its peers. Founded in 2015, the company is headquartered in Hyderabad, India.
Zenara Pharma's workforce has grown 16.7% from 2023 to 2026, up 6.1% year over year in 2026. It fell to a low of 304 in 2024 Q4 before recovering. Its workforce is concentrated most in South Asia (99.3%), followed by North America (0.7%).
Zenara Pharma's functional groups are Finance and Operations (49.8%), Sales and Marketing (27.6%), and Engineering (22.6%), with Sales and Marketing growing fastest (up 6.7%). The average salary is $10,647, highest in South Asia at a median of $8,000, down 3.8% year over year in 2026.
Zenara Pharma's hiring activity held steady in 2026. Overall employee sentiment is positive and broadly stable.
Sourced from Revelio Labs workforce data.
- Headquarters
- Hyderabad, India
- Founded
- 2015
- Industry
- Pharmaceuticals
- Employees
- 358
- YoY
- +6.1% (+42)
As of March 2026
Zenara Pharma workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Zenara Pharma. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsZenara Pharma Annual Employee Count (2023-2026)
- Zenara Pharma had 358 employees in 2026, a 6.1% increase (+42) from 2025.
- Zenara Pharma had 359 employees in 2025, a 6.5% increase (+55) from 2024.
- Zenara Pharma had 304 employees in 2024, a 1.6% increase (-25) from 2023.
- Zenara Pharma had 329 employees in 2023, a 4.8% increase (+25) from 2022.
Zenara Pharma's total workforce has grown from 307 employees in 2023 to 358 in 2026.
Zenara Pharma Pvt Ltd. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 358 | +42 | +6.1% |
| 2025 | Q4 | 359 | +55 | +6.5% |
| 2025 | Q3 | 358 | +28 | +0.6% |
| 2025 | Q2 | 336 | +2 | +2.3% |
| 2025 | Q1 | 316 | -17 | -1.4% |
| 2024 | Q4 | 304 | -25 | +1.6% |
| 2024 | Q3 | 330 | +9 | +9.2% |
| 2024 | Q2 | 334 | +27 | +11.2% |
| 2024 | Q1 | 333 | +16 | +7.8% |
| 2023 | Q4 | 329 | +25 | +4.8% |
| 2023 | Q3 | 321 | +32 | +0.5% |
| 2023 | Q2 | 307 | +56 | +5.9% |
See Zenara Pharma's complete headcount history, including quarterly breakdowns.
Get the DataZenara Pharma Employee Count by Region (2026)
South Asia accounts for the largest share of Zenara Pharma's global workforce with approximately 99% of total employees, followed by North America.
Zenara Pharma employees by region
| Region | Employees | % of Total |
|---|---|---|
| South Asia | 356 | 99.3% |
| North America | 3 | 0.7% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataZenara Pharma Employee Count by Department (2026)
Zenara Pharma's employee groups are Finance and Operations (49.8%), Sales and Marketing (27.6%), and Engineering (22.6%).
Zenara Pharma employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 178 | 49.8% |
| Sales and Marketing | 99 | 27.6% |
| Engineering | 81 | 22.6% |
Compare Zenara Pharma's department mix to industry peers.
See Full DataZenara Pharma Employee Salary by Region (2026)
Zenara Pharma's average employee salary is $10,647 globally. Employees in South Asia receive the highest compensation.
Zenara Pharma median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| South Asia | $8,000 |
Unlock salary by role, level, and city — and compare to Zenara Pharma's industry peers.
Unlock Salary DataZenara Pharma Job Openings and Hiring Trends (2023-2026)
- Zenara Pharma had 0 active job postings in 2026, a 0% no change from 2025.
- Zenara Pharma had 0 active job postings in 2025, a 0% no change from 2024.
- Zenara Pharma had 0 active job postings in 2024, a 0% no change from 2023.
- Zenara Pharma had 0 active job postings in 2023, a 0% no change from 2022.
- Hiring velocity in 2026: 0 new roles/month, up from 0 in 2025 and 0 in 2024.
Zenara Pharma's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataZenara Pharma Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Zenara Pharma's workforce based on public professional data. Overall sentiment is positive and has held steady year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Zenara Pharma
- How fast is Zenara Pharma growing?
- In 2026, Zenara Pharma's headcount grew 6.1% to 358 employees, up from 316 in 2025.
- See the full headcount history
- Where are Zenara Pharma employees located?
- Most Zenara Pharma employees are based in South Asia (99.3% of headcount), followed by North America.
- Explore where the workforce is based
- What is the average salary at Zenara Pharma?
- The average employee salary at Zenara Pharma is approximately $10.6k per year.
- Analyze the salary distribution
- How many new job postings does Zenara Pharma open per year?
- In Q1 2026, Zenara Pharma opened 0 new job postings. In 2025, Zenara Pharma opened 0 new job postings — about 0 per month.
- Track hiring trends by role
- When was Zenara Pharma founded and where is it headquartered?
- Zenara Pharma was founded in 2015 and is headquartered in Hyderabad, India.
- Compare Zenara Pharma to industry peers
Speak with a workforce expert about Zenara Pharma.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.